Navigation Links
$38.4M NHMRC program grants extend cancer and blood cell research
Date:3/8/2011

Institute research into how cancer develops and blood cell production and function will today be awarded $38.4 million under the National Health and Medical Research Council's (NHMRC) program grants scheme.

The nine Australian medical research programs that have been successful in securing $107 million in program grant funding will be announced at the Walter and Eliza Hall Institute by the Federal Minister for Mental Health and Ageing, the Honourable Mark Butler, at 10.15am on Tuesday 8 March.

Cancer researchers at the institute will receive $21.3 million to further research on the genetic changes that provoke cancer and to develop new approaches to its diagnosis, treatment and prevention. Ten scientists from five institute divisions will lead the research, with collaborators from the Burnet Institute and The Royal Melbourne Hospital.

Professor Jerry Adams, joint head of the institute's Molecular Genetics of Cancer division and one of the program's chief investigators, said the prospects seemed bright that the program would yield findings of great biological importance and lead to significant improvements in cancer treatment.

"We are now focused upon understanding two hallmarks of cancers: how they evade the body's normal program of cell death and how, like normal stem cells, they can multiply indefinitely," he said.

Professor Adams stressed that evasion of programmed cell death, also called apoptosis, is both a crucial step in tumour development and a major barrier to successful long-term treatment. "We discovered that cell death is often blocked in cancer cells, so we are now attempting to develop drugs that flip the natural 'cell death switch' back on," he said.

Understanding the stem-cell-like behaviour of cancers is also highly relevant to therapy, he said. "Certain cancers may be driven by 'rogue' stem cells that can escape current treatments and cause a relapse. If so, eradication of these rare cells within the bulk tumour will require development of novel therapies that target them."

The institute will also be leading a $17.1 million program to further studies of the molecular processes that regulate blood cell production and function. Scientists from the Cancer and Haematology, Molecular Medicine and Inflammation divisions will be collaborating on the project, led by Professor Nic Nicola, head of the institute's Cancer and Haematology division.

"The blood-forming system performs an intricately controlled balance of cell proliferation, maturation and functional activity that is essential for oxygen transport throughout the body, blood clotting, and effective immune responses," Professor Nicola said.

"Defining the genes and molecules that orchestrate blood cell production and function is crucial, not only for understanding the role of blood in health, but for establishing the basis of blood cell disorders and for devising new clinical strategies for fighting these lethal diseases, including leukaemia and autoimmune and inflammatory disorders."

Institute director Professor Doug Hilton said the NHMRC's program grants scheme provided vital support for Australian researchers to tackle complex but important research questions that might take many years to unravel.

"The program grants scheme is recognition that if Australian scientists are to continue to make discoveries that benefit human health they require sustained and significant support that brings together large research teams from diverse areas of medical research."


'/>"/>

Contact: Liz Williams
williams@wehi.edu.au
61-393-452-928
Walter and Eliza Hall Institute
Source:Eurekalert  

Related biology news :

1. European Multidisciplinary Conference in Thoracic Oncology -- press program
2. Reprogrammed stem cells hit a roadblock
3. Planetary exploration robots to be featured on science program WaveLengths
4. Human Cell joins Springers publishing program
5. Turfgrass fertility, pesticide programs compared
6. Some brain tumors mimic the genetic program of germline cells
7. Massachusetts General Hospitals Warren Triennial Prize to honor pioneers of cellular reprogramming
8. UCSF team develops logic gates to program bacteria as computers
9. Drug discovery programs boosted
10. Pitt researcher receives NIH funding for technology-enhanced weight-loss program
11. Agilent Technologies Expands Agreement to Offer AMDeC Members Preferential Pricing on Products Through AMDeC F.I.R.S.T.™ Vendor Partnership Program
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
$38.4M NHMRC program grants extend cancer and blood cell research
(Date:6/14/2017)... (NYSE: IBM ) is introducing several innovative partner startups ... collaboration between startups and global businesses, taking place in ... nine startups will showcase the solutions they have built with ... France is one of the ... percent increase in the number of startups created between 2012 ...
(Date:5/16/2017)... May 16, 2017  Veratad Technologies, LLC ( www.veratad.com ... age and identity verification solutions, announced today they will ... 2017, May 15 thru May 17, 2017, in ... International Trade Center. Identity impacts the ... in today,s quickly evolving digital world, defining identity is ...
(Date:5/6/2017)... , May 5, 2017 ... just announced a new breakthrough in biometric authentication ... exploits quantum mechanical properties to perform biometric authentication. These ... smart semiconductor material created by Ram Group and ... finance, entertainment, transportation, supply chains and security. Ram ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS ... the addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US ... absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... , Oct. 11, 2017  VMS BioMarketing, a leading provider ... nationwide oncology Clinical Nurse Educator (CNE) network, which will launch ... for communication among health care professionals to enhance the patient ... office staff, and other health care professionals to help women ... cancer. ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
Breaking Biology Technology: